Nasdaq · CIK 0001926599
TDAC Translational Development Acquisition Corp.
Insider trading from SEC Form 4. Last filing May 29, 2026.
In brief
Translational Development Acquisition Corp. (TDAC) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on May 29, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Translational Development Acquisition Corp., scored.
Transactions
Every row filed, 1 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | Michael B Hoffman Chairman and CEO | POpen-market purchase Warrantsderivative | +53,395 | $0.79 | $42k | 53,395 | May 29, 2026 |
Questions about TDAC
Answered from the filings on this page, as of the latest one.
Are insiders buying TDAC?
No. In the last 90 days no insider at Translational Development Acquisition Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TDAC on the open market?
No open-market trade has been scored at Translational Development Acquisition Corp.. The latest Form 4 on file was filed on May 29, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Translational Development Acquisition Corp.?
1 person has filed a Form 4 at Translational Development Acquisition Corp., among them Michael B Hoffman (Chairman and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.